- Added to Email Alerts
Antiretroviral Therapy
Latest News View All
-
AIDS 2024PURPOSE 1 Lenacapavir Results 'Highly Anticipated' -
No HIV Infections After Twice-a-Year PrEP -
CROI 2024New Once-Daily HIV Oral Alternative Advances -
WHO Warns Of Growing Resistance to GSK's HIV Drug
-
GSK's Injectable HIV Drug Shows Promise Over Daily Pills
-
Long-Acting PrEP in Europe's Fight Against HIV -
ANAC 2023No Longer a Death Sentence, HIV Diagnosis Still Hits Hard
-
ANAC 2023Long-Acting Antiretrovirals for HIV Improve Adherence
Perspective View All
Journal Articles View All
-
Atorvastatin vs Aspirin in People With HIV
-
Breakthrough HIV-1 Infection After CAB-LA for HIV PrEP
-
Treatment Failure in Severe Mpox Patient With Untreated HIV
-
Preference for Daily Oral Pills vs Long-Acting ART for HIV
-
Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox
-
Impact of COVID-19 on HIV Adolescent Programming
Additional Resources
Medscape Drugs & Diseases
- Antiretroviral Therapy for HIV Infection
- Cutaneous Manifestations of HIV Disease
- HIV Disease
- HIV in Pregnancy
- Pediatric HIV Infection
Medscape Education